Pamela Cope
Adult Health · Dallas, TXNPI 1023422300
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,160 and has fallen 98.8% since, to $14 in 2023.
Across 69 payments — averaging $17.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$149
- Novo Nordisk$144
- Amgen$134
- Boehringer Ingelheim$95
- Mannkind Corporation$91
- AbbVie$81
- plus $499 from 17 others
What the payments were for
- Food & beverage$1,193100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 8 | $149 |
| Novo Nordisk | 8 | $144 |
| Amgen | 8 | $134 |
| Boehringer Ingelheim | 6 | $95 |
| Mannkind Corporation | 6 | $91 |
| AbbVie | 4 | $81 |
| Radius Health, Inc. | 2 | $53 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Abbott | 3 | $53 |
| Amarin Pharma, Inc. | 3 | $50 |
| Merck | 3 | $45 |
| Xeris Pharmaceuticals, Inc. | 2 | $44 |
| Lilly USA, LLC | 2 | $36 |
| Antares Pharma, Inc. | 2 | $31 |
| IBSA Pharma Inc. | 1 | $22 |
| Esperion Therapeutics, Inc. | 1 | $16 |
| Amneal Pharmaceuticals LLC | 1 | $15 |
| Pfizer | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Tandem Diabetes Care, Inc. | 1 | $14 |
| Medtronic | 1 | $13 |
| Clarus Therapeutics Inc. | 1 | $12 |
| Vivus LLC | 1 | $11 |
How this compares
$1,193 in reported general payments places this provider in the 65th percentile of 933 adult health providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 46 | $2,273 |
Paid to pharmacies, not to this prescriber.
Other adult health in Dallas
- Melodie YoungDallas$700K
- Eric KlappholzDallas$44K
- Megan WheelerDallas$13K
- Joseph SchillDallas$7K
- Misty SheddAllen$863K
- Cynthia BedellPlano$168K
- Elizabeth Wedberg SivamAustin$71K
- Mary SalazarSan Antonio$68K
- Christin TouchetKingwood$43K
- Yulia LyuboslavskyAustin$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.